Gottlieb AB - Search Results

1

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.

Gottlieb AB, Hamilton T, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Gottlieb AB, et al. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S154-63. doi: 10.1016/j.jaad.2005.12.018. J Am Acad Dermatol. 2006. PMID: 16488337 Clinical Trial.

2

The challenges of treating moderate to severe psoriasis.

Gottlieb AB. Gottlieb AB. Int J Dermatol. 1997 Dec;36 Suppl 1:41-4. doi: 10.1046/j.1365-4362.36.s1.4.x. Int J Dermatol. 1997. PMID: 9466222 Review. No abstract available.

3

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.

Gottlieb A, Krueger JG, Bright R, Ling M, Lebwohl M, Kang S, Feldman S, Spellman M, Wittkowski K, Ochs HD, Jardieu P, Bauer R, White M, Dedrick R, Garovoy M. Gottlieb A, et al. J Am Acad Dermatol. 2000 Mar;42(3):428-35. doi: 10.1016/s0190-9622(00)90214-7. J Am Acad Dermatol. 2000. PMID: 10688712

4

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions.

Oh CJ, Das KM, Gottlieb AB. Oh CJ, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2000 May;42(5 Pt 1):829-30. doi: 10.1067/mjd.2000.105948. J Am Acad Dermatol. 2000. PMID: 10775863

5

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.

Krueger JG, Walters IB, Miyazawa M, Gilleaudeau P, Hakimi J, Light S, Sherr A, Gottlieb AB. Krueger JG, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2000 Sep;43(3):448-58. doi: 10.1067/mjd.2000.106515. J Am Acad Dermatol. 2000. PMID: 10954656 Clinical Trial.

6

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

Gottlieb AB, Lebwohl M, Shirin S, Sherr A, Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E, Phillips S, Neisler HM, Krueger JG. Gottlieb AB, et al. J Am Acad Dermatol. 2000 Oct;43(4):595-604. doi: 10.1067/mjd.2000.107945. J Am Acad Dermatol. 2000. PMID: 11004613 Clinical Trial.

7

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Chaudhari U, et al. Among authors: gottlieb ab. Lancet. 2001 Jun 9;357(9271):1842-7. doi: 10.1016/s0140-6736(00)04954-0. Lancet. 2001. PMID: 11410193 Clinical Trial.

8

Psoriasis. Immunopathology and immunomodulation.

Gottlieb AB. Gottlieb AB. Dermatol Clin. 2001 Oct;19(4):649-57, viii. doi: 10.1016/s0733-8635(05)70306-5. Dermatol Clin. 2001. PMID: 11705352 Review.

9

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

Gottlieb AB, Krueger JG, Wittkowski K, Dedrick R, Walicke PA, Garovoy M. Gottlieb AB, et al. Arch Dermatol. 2002 May;138(5):591-600. doi: 10.1001/archderm.138.5.591. Arch Dermatol. 2002. PMID: 12020219 Clinical Trial.

10

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody.

Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, Chaudhari U, Allen RS, Lizambri RG. Gottlieb AB, et al. J Am Acad Dermatol. 2002 Nov;47(5):692-700. doi: 10.1067/mjd.2002.124698. J Am Acad Dermatol. 2002. PMID: 12399760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters